Category:
Prophylactic Biological Products
This topical gel combines Collagen NLT 90%, Mupirocin 2%, and Metronidazole 1% for advanced wound care. Collagen provides a scaffold; Mupirocin (CAS 17076-04-9) targets Gram-positive bacteria, while Metronidazole (CAS 443-48-1) treats anaerobes. The formulation utilizes emulsion technology to ensure stability.
Avoid occlusive dressings unless specified. Store below 25°C in dry conditions. Contraindicated in patients with hypersensitivity to mupirocin or nitroimidazoles. Use under strict medical supervision.